ASX Share rice
Thu 13 May 2021 - 01:17:pm (Sydney)

RAC Share Price

RACE ONCOLOGY LTDRACPharmaceuticals, Biotechnology & Life Sciences

RAC Company Information

Name:

Race Oncology Limited

Sector:

Healthcare

Industry:

Biotechnology

GIC Industry:

Biotechnology

GIC Sub Industry:

Biotechnology

Address:

Gateway 1 Macquarie Place Sydney NSW Australia 2000

Phone:

61 3 9098 8750

CEO, MD & Director:

Mr. Phillip R. Lynch

Chief Scientific Officer & Exec. Director:

Dr. Daniel Tillett

Chairman of Clinical Advisory Board & Chief Medical Officer:

Prof. Borje S. Andersson

Company Sec.:

Mr. Peter Gordon Webse M.A.I.C.D., B.Bus, FGIA, FCIS, FCPA, MAICD

Company Overview:

Race Oncology Limited operates as a specialty pharmaceutical company in Australia. The company is developing Bisantrene, a small molecule cancer chemotherapy drug that is used for the treatment of acute myeloid leukaemia. It has a preclinical research program with the University of Newcastle to explore the use of Bisantrene to treat melanoma. The company was formerly known as Coronado Resources Limited and changed its name to Race Oncology Limited in July 2016. Race Oncology Limited was incorporated in 2011 and is based in Sydney, Australia.

RAC Share Price Information

Shares Issued:

141.08M

Market Capitalisation:

$455.69M

Revenue (TTM):

$387.39K

Revenue Per Share (TTM):

$0

Earnings per Share:

$-0.046

Operating Margin (TTM):

$-11.67

Return On Assets (TTM):

$-0.37

Return On Equity (TTM):

$-0.59

Quarterly Revenue Growth (YOY):

1.431

Gross Profit(TTM):

$-283,819

Diluted Earnings Per Share (TTM):

$-0.037

RAC CashFlow Statement

CashFlow Date:

2020-06-30

Change To Liabilities:

$51.53K

Net Income:

$-3,845,965

Total Cash From Operating Activities:

$-2,463,083

Depreciation:

$281.20K

Change To Account Receivables:

$-48,304

Sale Purchase Of Stock:

$3.35M

Capital Expenditures:

$0

RAC Income Statement

Income Date:

2020-06-30

Income Before Tax:

$-3,845,970

Net Income:

$-3,845,970

Operating Income:

$-3,859,720

Other Operating Expenses:

$137.96K

Total Revenue:

$9.32K

RAC Balance Sheet

Balance Sheet Date:

2020-06-30

Intangible Assets:

$3.94M

Total Liabilities:

$243.65K

Total Stockholder Equity:

$5.69M

Total Assets:

$5.93M

Common Stock:

$19.66M

Other Current Assets:

$182.74K

Retained Earnings:

$-15,770,560

Cash:

$1.73M

Total Current Liabilities:

$243.65K

Net Tangible Assets:

$1.75M

Total Current Assets:

$2M

Net Receivables:

$48.92K

Short-Term Investments:

$3.94M

Accounts Payable:

$132.57K

Short-Term Investments:

$3.94

Non Current Liabilities Total:

$0

RAC Share Price History

RAC News

03 Mar, 2021
Even when a business is losing money, it's possible for shareholders to make money if they buy a good business at the...
28 Oct, 2020
The big shareholder groups in Race Oncology Limited (ASX:RAC) have power over the company. Large companies usually...